neurological diseases
The involvement of ionotropic AMPA receptors in the pathogenesis of neurological diseases
... other neurological diseases (Sriram et ...the neurological features o f the disease suggest a major contribution of axonal and neuronal impairment and/or ...
211
Biomarker discovery in neurological diseases: a metabolomic approach
... The introduction and concepts of metabolomics enabling the study of neurological diseases based on profiling a multitude of biochemical components related to brain metabolism. This approach is considered to ...
15
Death Characteristics of Neurological Diseases in Inner Mongolia between 2008 and 2015
... rological diseases to be generally higher in males than in females, and this may be related to differences in gene expression in the brains of males and females ...for neurological diseases increased ...
8
Predicting targets of compounds against neurological diseases using cheminformatic methodology
... Our current methodology has confirmed to enhance the predictive power of the CFP representations, and that the filtering and refinement of ChEMBL families enriches our results. The refined ChEMBL dataset and our protein ...
48
CT & MR Imaging of Neurological Diseases in Pregnancy and Puerperium
... Yourself Mrs ………………………….. are being asked to be a participant in the research study titled CT and MR Imaging of Neurological diseases in Pregnancy and Puerperium in CMC hospital, Coimbatore, Conducted by ...
131
Cerebrospinal fluid dynamics and intracranial pressure elevation in neurological diseases
... The fine balance between the secretion, composition, volume and turnover of cerebrospinal fluid (CSF) is strictly regulated. However, during certain neurological diseases, this balance can be disrupted. A ...
18
Hapln2 in neurological diseases and its potential as therapeutic target
... FIGURE 2 | Possible roles of Hapln2 in Parkinson’s disease (PD), Alzheimer’s disease (AD), and schizophrenia. An upregulation of Hapln2 is observed in the substantia nigra (SN) of PD brain. The high expression levels of ...
7
Therapeutic potential of Hsp27 in neurological diseases
... Hsp27: Hsp27, in particular, has shown to be involved in cell viability and actin cytoskeleton remodeling and also shown to improve many disease conditions. Phosphorylated Hsp27 modulates the p53 pathway by ...
8
Induced pluripotent stem cells in the study of neurological diseases
... modeling neurological disorders, including the demonstration of disease- specifi c phenotypes in iPS cell-derived neurons generated from patients with spinal muscular atrophy, familial dysautonomia, Rett syndrome, ...
9
Interactions between Physicians and Patients with Neurological Diseases in Albania
... with neurological chronic illness is more difficult in communication and what are the reasons that hinder communication, 80% of neurological doctors answer that patients with chronic neurological ...
5
Serum IgG against Simian Virus 40 antigens are hampered by high levels of sHLA G in patients affected by inflammatory neurological diseases, as multiple sclerosis
... inflammatory diseases (OIND), non-inflam- matory neurological diseases (NIND) and healthy sub- jects (HS) (i) carry SV40-antibodies, (ii) present different levels of soluble HLA-G molecules, (iii) ...
6
Pyroptosis and neurological diseases
... Pyroptosis is a new process of programmed cell death, which has been discovered and confirmed in recent years. Its cardinal features include activation of caspase‑1 and a massive release of inflammatory cytokines ...
6
Cerebral Waste Accumulation and Glymphatic Clearance as Mechanisms of Human Neurological Diseases
... a neurological disease that can develop independent of head trauma, since in both CTE and TLE: 1) Extracellular p-tau followed unidirectional, fluid-driven pathways that led toward the space bordering large ...
5
Neuroimmune crosstalk in the central nervous system and its significance for neurological diseases
... Neurons, glial and immune cells form a coordinated network to maintain the homeostasis and restrict neu- roinflammation in the CNS. This integrative network is not only involved in the pathogenesis of neuroinflamma- ...
10
The orexin/receptor system : molecular mechanism and therapeutic potential for neurological diseases
... of neurological diseases such as narcolepsy, depression, ischemic stroke, drug addiction and Alzheimer’s disease ...in neurological diseases, providing an overall framework for considering ...
16
Application of CRISPR genetic screens to investigate neurological diseases
... and non-dividing cells, unlike retroviruses that can only transduce dividing cells. Thus, lentiviruses are better suited for conducting CRISPR-Cas9 functional genomics screens in in vivo or ex vivo neurological ...
16
Advance care planning in progressive neurological diseases: lessons from ALS
... Our data indicate that the clearly structured follow-up of patients with MND facilitates maintenance of ACP. Our participants counted on the regular check-up of their overall health status and knew that (imminent) de- ...
10
Role of cholesterol and sphingolipids in brain development and neurological diseases
... myelination and is also essential for development and functional outcomes. Sufficient availability of cholesterol for synapse formation is a critical step in the structural and functional development of our nervous ...
12
VITAMIN D IN NEUROLOGICAL DISEASES: A RATIONALE FOR A PATHOGENIC IMPACT
... Vitamin D deficiency is associated with an increased risk of vascular disease and ischemic stroke in healthy subjects,.. the risk is higher for ischemic stroke than for hemorrha[r] ...
40
Sodium thiosulfate attenuates glial-mediated neuroinflammation in degenerative neurological diseases
... Effect of treatment with NaSH and STS on SH-SY5Y cell viability changes induced by LPS/IFN γ -activated THP-1 cell CM (A) or IFN γ -activated U373 cell CM (B) as followed by MTT assays ([r] ...
14